• Title of article

    TF-XRD examination of surface-reactive TiO2 coatings produced by heat treatment and CO2 laser treatment

  • Author/Authors

    Niko Moritz، نويسنده , , Sami Areva، نويسنده , , Joop Wolke، نويسنده , , Timo Peltola، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2005
  • Pages
    8
  • From page
    4460
  • To page
    4467
  • Abstract
    When surface-reactive (bioactive) coatings are applied to medical implants by means of CO2 laser processing, the bioactivity of the surface of the implant can be locally modified to match the properties of the surrounding tissues to provide a firm fixation of the implant. The aim of this study was to compare the heat treated TiO2 coatings with the laser-treated TiO2 coatings in terms of amorphous-crystalline-phase development. The coatings were characterized with thin-film X-ray diffraction (TF-XRD), atomic force microscopy (AFM) and scanning electron microscopy (SEM). The TiO2 coatings heat treated at 500 °C known to be bioactive in SBF (simulated body fluid) consisted mainly of anatase with some rutile-phase, suggesting a predominant effect of anatase on reactivity of coatings. However, the coatings preheat-treated at 500 °C with further laser treatment exhibited enhanced bioactivity while consisting mainly of rutile. These findings indicated a key role of both rutile and anatase for the reactivity of the coatings. Without preheat treatment, by laser treatment alone, the amorphous titania coatings developed into mixed anatase/rutile containing coatings. This structural organization and the increase in crystal size are thus considered to be the reasons for their bioactivity. The SBF results indicate the possibility to control bioactivity by altering laser power used through the anatase/rutile crystallinity enhancement.
  • Keywords
    Titanium oxide , laser , Crystallinity , bioactivity , in vitro , Bioactive , Coatings , CO2 laser
  • Journal title
    Biomaterials
  • Serial Year
    2005
  • Journal title
    Biomaterials
  • Record number

    546277